ÂÜÀòÂÒÂ×

Sarah Podlogar is currently serving as Associate Director at Omeros Corporation, focusing on Narsoplimab, after previously holding the position of Senior Product Manager in Hematology/Oncology at The Janssen Pharmaceutical Companies of Johnson & Johnson. Sarah has extensive experience in global market access, health economics, and research analysis in various healthcare settings, including Boston Scientific, Cornerstone Research Group Inc., Europe Economics, and Latin Markets. Sarah holds a Master's degree in International Health Policy from The London School of Economics and Political Science and a Bachelor's degree in Economics from New York University.